Japan Agency for Medical Research and Development (AMED)

Funding rounds backed by Japan Agency for Medical Research and Development (AMED).

Export CSV
Funding disclosed in full
$32M
Median round
$32M
Rounds in calculation
1
1 round
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
EpiFrontier Therapeutics

Develops novel therapies for beta globin disorders

$32MGrantBiotechUnited States
1 participantJapan Agency for Medical Research and Development (AMED)